News Daily News CAC Screening Stratifies CVD Event Risk in Statin-Eligible Patients: Heinz Nixdorf Recall Study Michael O'Riordan September 22, 2016
News Industry News Amgen Announces Positive Top-Line Results From Phase 3 GLAGOV Imaging Study Of Repatha® (Evolocumab) September 20, 2016
News Conference News ESC 2016 When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis Michael O'Riordan August 31, 2016
News Conference News ESC 2016 Focus on LDL Cholesterol Targets With Statin Therapy, New ESC-EAS Cholesterol Guidelines Say Michael O'Riordan August 27, 2016
News Daily News Neighborhood Access to Healthy Food Affects Residents’ Risk of Atherosclerosis Leah Lawrence August 22, 2016
News Daily News El Acceso a Alimentos Saludables de los Vecindarios Influye en el Riesgo de Aterosclerosis de los Residentes Leah Lawrence August 22, 2016
News Daily News The EU Versus US Lipid Guideline Debate: It’s the Gap That Matters, Experts Say Shelley Wood July 19, 2016
News Daily News Debate Directrices EU vs. EE.UU: Según los Expertos las Diferencias son Importantes Shelley Wood July 19, 2016
News Daily News Un Nuevo Análisis Cuestiona el Mantra ‘Mejor Menos’, aunque los Expertos Piden Cautela Todd Neale June 22, 2016
News Daily News ‘Lower Is Better’ Mantra for LDL Cholesterol Questioned by New Analysis, but Experts Urge Caution Todd Neale June 22, 2016
News Daily News Detection and Treatment of Severe FH Depends on LDL Levels, Not Genes, Says Expert Panel Michael O'Riordan June 09, 2016
News Daily News El Debate Sigue Abierto: ¿Sobrevalora la Calculadora de la Enfermedad Cardiovascular Aterosclerótica el Riesgo de los Pacientes? Yael L. Maxwell May 04, 2016
News Daily News Does the Atherosclerotic Cardiovascular Disease Calculator Overestimate Patient Risk? The Debate Continues Yael L. Maxwell May 04, 2016
News Daily News ACC Updates LDL-Cholesterol Lowering Recommendations, Making Room for Ezetimibe and PCSK9 Inhibitors Michael O'Riordan April 02, 2016